ESMO-Advanced-Courses-Biomarkers for Precision Medicine-2022-1000x250-november

Start date: 25 Nov 2022
End date: 26 Nov 2022
Location: Zurich, Switzerland

Learning objectives

To recognize the different modalities of molecular assays needed for contemporary practice of precision oncology
To determine the different technologies available for biomarker testing and the context where these technologies are most effective, depending on the nature of the biomarker and the availability of biological samples
To comprehend the different modalities of cfDNA testing and their applications in disease monitoring, development of resistance, and minimal residual disease assessment
To recognize the applications of multiplex immunophenotyping, spatial transcriptomics and artificial intelligence applied to tissue samples
To define the contribution of multidisciplinary teams and tumour boards for therapy decision making

Accreditation

The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Samra Turajlic, United Kingdom
Ben Westphalen, Germany

Learning objectives

Accreditation

Co-Chairs

Supported by